↓ Skip to main content

The ORVAC trial: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection…

Overview of attention for article published in Trials, August 2020
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The ORVAC trial: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: a statistical analysis plan
Published in
Trials, August 2020
DOI 10.1186/s13063-020-04602-w
Pubmed ID
Authors

Mark A Jones, Todd Graves, Bianca Middleton, James Totterdell, Thomas L Snelling, Julie A Marsh

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 16%
Student > Postgraduate 3 9%
Librarian 2 6%
Student > Master 2 6%
Professor 1 3%
Other 1 3%
Unknown 18 56%
Readers by discipline Count As %
Medicine and Dentistry 5 16%
Mathematics 2 6%
Nursing and Health Professions 2 6%
Agricultural and Biological Sciences 1 3%
Environmental Science 1 3%
Other 2 6%
Unknown 19 59%